1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Clinical characteristics of study patients
MelanomaLung
Patients3123
Average age (y)59.6 (SD 14.0)62.5 (SD 10.2) (P = .40)
Sex (M:F)23:89:14 (P < .01)
Systemic metastasis*94% (29/31)35% (8/23) (P < .01)
Primary
    Skin27
    Ocular1
    Unknown3
    NSCLC20
    SCLC3
  • Notes:—NSCLC indicated non-small cell lung carcioma; SCLC, small cell lung carcioma.
  • * Present at time of brain metastasis diagosis.